Longevity science has shifted from theory to commercial reality. With breakthroughs in aging biology, AI-driven drug development, and new regulatory pathways, pharma can now target the root mechanisms of aging. This blog reveals why aging is finally druggable, and how Anervea.AI® accelerates this new era of therapeutics.